Andreas began his career in banking in 1994, but quickly transitioned to the life sciences industry in 2001. Over the years, he has held several key roles, including CFO, consultant, founder, advisory board member, and investor. His impressive track record includes major positions at companies such as Direvo Biotech AG, 4-Antibody AG, Ayoxxa Biosystems GmbH, Fit Analytics GmbH, and Ferrosens GmbH, where he played pivotal roles in financing rounds and executing four exits. Currently, Andreas serves as the CFO at Navigo Proteins GmbH, bringing a wealth of expertise to their operations. With his hands-on experience in operational management and extensive financial expertise, Andreas is a tremendous asset to any life science venture